Mpox immunity under the microscope: new study tracks lasting protection
NCT ID NCT07592429
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well the body remembers mpox after an infection. Researchers will measure antibodies and special immune cells in 60 people who had mpox. The goal is to understand how long protection might last and how strong it is.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MPOX (MONKEYPOX) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI toolkit aims to speed up epidemic response for diseases like COVID-19 and mpox
- Mpox vaccine trial targets HIV-Positive adults in DRC
- Mpox vaccine trial for infants: could a Half-Dose protect just as well?
- Mpox study in guinea aims to unlock secrets of virus spread and vaccine power
- Mpox's hidden toll on eyes revealed in new study
- New mRNA vaccine against mpox enters key trial in africa